Algeria vs Fiji: Death rate from Parkinson's disease
Algeria
2.38 deaths per 100,000 people
in 2021
Fiji
2.45 deaths per 100,000 people
in 2021
Algeria rank
98th
Fiji rank
95th
Death rate from Parkinson's disease over time
- Algeria
- Fiji
How they compare
Fiji currently reports 2.45 deaths per 100,000 people against 2.38 deaths per 100,000 people in Algeria, a difference of 0.07 deaths per 100,000 people.
Across all 22 years both countries report, Fiji has been ahead every year.
Algeria ranks 98th and Fiji ranks 95th of 194 countries.
Fiji has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Algeria | Fiji | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.56 deaths per 100,000 people | 2.03 deaths per 100,000 people | 0.464 deaths per 100,000 people | Fiji |
| 2010s | 1.91 deaths per 100,000 people | 2.31 deaths per 100,000 people | 0.396 deaths per 100,000 people | Fiji |
| 2020s | 2.35 deaths per 100,000 people | 2.53 deaths per 100,000 people | 0.18 deaths per 100,000 people | Fiji |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from parkinson's disease, Algeria or Fiji?
- Fiji, at 2.45 deaths per 100,000 people against 2.38 deaths per 100,000 people in Algeria as of 2021.
- What is the difference in death rate from parkinson's disease between Algeria and Fiji?
- 0.07 deaths per 100,000 people, with Fiji ahead.
- How many years of comparable data are there for Algeria and Fiji?
- 22 years are reported by both, from 2000 to 2021.
- How do Algeria and Fiji rank globally for death rate from parkinson's disease?
- Algeria ranks 98th and Fiji ranks 95th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Death rate from Parkinson's disease. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from parkinson disease in both sexes, per 100,000 people.